
Washington: A new experiment has discovered that patients suffering from 'blinding' headaches known as Idiopathic Intercranial Hypertension (IIH) might be treated with an injectable peptide used to treat type 2 diabetes.

Washington: A new experiment has discovered that patients suffering from 'blinding' headaches known as Idiopathic Intercranial Hypertension (IIH) might be treated with an injectable peptide used to treat type 2 diabetes.